◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Consun Pharmaceutical Group Limited (1681) Financial History

Name: Consun Pharmaceutical Group Limited (1681) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Consun Pharmaceutical Group Limited (1681) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Guangzhou, China with about 3,115 employees. Its market capitalization is roughly CNY 12 billion. In the fiscal year ended 2025-12-31, 1681 reported CNY 3.4B in revenue and CNY 1.1B in net income.

Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China. It operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical.

Interactive charts & full statements →

1681 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 3.4B	CNY 3.0B	CNY 2.6B	CNY 2.3B	—
Gross Profit	CNY 2.7B	CNY 2.2B	CNY 1.9B	CNY 1.8B	—
Operating Income (EBIT)	CNY 1.2B	CNY 963M	CNY 810M	CNY 720M	—
Net Income	CNY 1.1B	CNY 910M	CNY 784M	CNY 683M	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1681 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 498M)	(CNY 680M)	(CNY 326M)	(CNY 128M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1681 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 6.4B	CNY 5.9B	CNY 5.5B	CNY 4.9B	—
Total Liabilities	CNY 1.6B	CNY 1.5B	CNY 1.6B	CNY 1.5B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1681 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

2929 · Pharma Foods International Co., Ltd. — $17 billion
2637 · Fujian Haixi Pharmaceuticals Co., Ltd. — $15 billion
IPN · Ipsen S.A. — $13 billion
4574 · Taiko Pharmaceutical Co.,Ltd. — $13 billion
2627 · Ab&B Bio-Tech CO., LTD. JS — $12 billion
4524 · Morishita Jintan Co., Ltd. — $9 billion
4512 · Wakamoto Pharmaceutical Co.,Ltd. — $9 billion
2186 · Luye Pharma Group Ltd. — $8 billion

← 1680 All “0-9” companies 1682 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.